{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:45:33Z","timestamp":1784598333565,"version":"3.55.0"},"reference-count":48,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002510","name":"Kongju National University","doi-asserted-by":"publisher","award":["2024-0325-01"],"award-info":[{"award-number":["2024-0325-01"]}],"id":[{"id":"10.13039\/501100002510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Life"],"abstract":"<jats:p>This study aims to investigate the effects of continuous glucose monitoring (CGM) on glycemic control in patients with diabetes mellitus (DM) and to identify the sociodemographic or health behavioral factors that influence the outcomes. The data were collected from 510 diabetic patients prescribed to use CGM for 12 weeks and analyzed using SPSS 27.0. Paired samples t-tests were used to compare the glycemic control (HbA1c and fasting glucose) and metabolic health (body mass index and total cholesterol) measures of subjects before and after the CGM use, and independent t-tests were conducted to examine whether the effectiveness of CGM differs according to subjects\u2019 sociodemographic and health behavioral characteristics. As a result of this study, the use of CGM resulted in a significant reduction in HbA1c from 8.09 to 7.48 percent (p &lt; 0.001) and in fasting glucose from 152.41 to 137.16 mg\/dL (p &lt; 0.001). In the subgroup analysis of CGM effectiveness, fasting glucose reduction was greater in females than in males and in patients with type 2 diabetes than in those with type 1 diabetes. In conclusion, it is essential to consider patient characteristics to enhance the effectiveness of CGM and to expand its use to type 2 diabetes to reduce the social burden of the disease.<\/jats:p>","DOI":"10.3390\/life15101543","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:06:02Z","timestamp":1759316762000},"page":"1543","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Expanding the Use of Continuous Glucose Monitoring in Type 2 Diabetes Mellitus: Impact on Glycemic Control and Metabolic Health"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2008-4371","authenticated-orcid":false,"given":"Mi-Joon","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Medical Information, Kongju National University, 56 Gongjudaehak-ro, Gongju-si 32588, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4387-1263","authenticated-orcid":false,"given":"Bum-Jeun","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Medical Information, Kongju National University, 56 Gongjudaehak-ro, Gongju-si 32588, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyoung","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K.B., Ostolaza, H., and Mart\u00edn, C. (2020). Pathophysiology of Type 2 Diabetes Mellitus. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176275"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1573403X1604201229115531","article-title":"Complications of the type 2 diabetes mellitus","volume":"16","author":"Farmaki","year":"2020","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-021-05585-2","article-title":"Interpreting global trends in type 2 diabetes complications and mortality","volume":"65","author":"Ali","year":"2022","journal-title":"Diabetologia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/dci23-0041","article-title":"Cardiovascular and kidney risks in individuals with type 2 diabetes: Contemporary understanding with greater emphasis on excess adiposity","volume":"47","author":"Sattar","year":"2024","journal-title":"Diabetes Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2337\/dc18-1131","article-title":"Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes","volume":"41","author":"Lu","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/dc20-1862","article-title":"Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: A prospective cohort study","volume":"44","author":"Lu","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","article-title":"Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"65","author":"Davies","year":"2022","journal-title":"Diabetologia"},{"key":"ref_8","unstructured":"Federation, I.D. (2025, July 24). IDF Diabetes Atlas. Available online: https:\/\/diabetesatlas.org\/."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s13300-022-01254-8","article-title":"Self-monitoring of blood glucose as an integral part in the management of people with type 2 diabetes mellitus","volume":"13","author":"Pleus","year":"2022","journal-title":"Diabetes Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4018\/IJEHMC.20211101.oa12","article-title":"Automated glucose control: A review","volume":"12","author":"Bhat","year":"2021","journal-title":"Int. J. E-Health Med. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00592-020-01589-3","article-title":"Effects of real-time continuous glucose monitoring in type 1 diabetes: A meta-analysis of randomized controlled trials","volume":"58","author":"Dicembrini","year":"2021","journal-title":"Acta Diabetol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1758-5996-5-39","article-title":"Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes","volume":"5","author":"Poolsup","year":"2013","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2337\/dc18-1150","article-title":"Clinical implications of real-time and intermittently scanned continuous glucose monitoring","volume":"41","author":"Edelman","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.diabres.2017.08.005","article-title":"Continuous glucose monitoring: A review of the technology and clinical use","volume":"133","author":"Klonoff","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/dc17-0133","article-title":"The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: Further findings from the DIAMOND randomized clinical trial","volume":"40","author":"Polonsky","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_17","unstructured":"Korean Ministry of Food and Drug Safety (2025, April 17). 2023 Medical Device Approval Report. Available online: https:\/\/www.mfds.go.kr\/brd\/m_218\/down.do?brd_id=data0013&seq=33580&data_tp=A&file_seq=1."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1089\/dia.2023.0513","article-title":"Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis","volume":"26","author":"Kim","year":"2024","journal-title":"Diabetes Technol. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4093\/dmj.2021.0156","article-title":"2021 clinical practice guidelines for diabetes mellitus in Korea","volume":"45","author":"Hur","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1054773816666280","article-title":"Why is the one-group pretest\u2013posttest design still used?","volume":"25","author":"Knapp","year":"2016","journal-title":"Clin. Nurs. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e12162","DOI":"10.1111\/jspn.12162","article-title":"Effectiveness of continuous glucose monitoring in children, adolescents, and young adults with poorly controlled type 1 diabetes","volume":"22","author":"Lewis","year":"2017","journal-title":"J. Spec. Pediatr. Nurs."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"BMI-S38440","DOI":"10.4137\/BMI.S38440","article-title":"Significance of HbA1c test in diagnosis and prognosis of diabetic patients","volume":"11","author":"Sherwani","year":"2016","journal-title":"Biomark. Insights"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2025). 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142025. Diabetes Care, 48, S27\u2013S49.","DOI":"10.2337\/dc25-S002"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12933-020-01200-7","article-title":"Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications","volume":"20","author":"Sun","year":"2021","journal-title":"Cardiovasc Diabetol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Wu, Y., Li, D., and Vermund, S.H. (2024). Advantages and Limitations of the Body Mass Index (BMI) to Assess Adult Obesity. Int. J. Environ. Res. Public Health., 21.","DOI":"10.3390\/ijerph21060757"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7570\/jomes23031","article-title":"Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of Obesity","volume":"32","author":"Haam","year":"2023","journal-title":"J. Obes. Metab. Syndr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.2147\/DMSO.S317739","article-title":"Effect of metabolic health and obesity phenotype on risk of diabetes mellitus: A population-based longitudinal study","volume":"14","author":"Zhu","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"969080","DOI":"10.3389\/fendo.2022.969080","article-title":"The association between blood glucose levels and lipids or lipid ratios in type 2 diabetes patients: A cross-sectional study","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.7573\/dic.2021-9-13","article-title":"Diabetes: The role of continuous glucose monitoring","volume":"11","author":"Kluemper","year":"2022","journal-title":"Drugs Context"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/dia.2019.0369","article-title":"Self-monitoring of blood glucose requirements with the use of intermittently scanned continuous glucose monitoring","volume":"22","author":"Reddy","year":"2020","journal-title":"Diabetes Technol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41747-020-0145-y","article-title":"Statistical significance: P value, 0.05 threshold, and applications to radiomics\u2014Reasons for a conservative approach","volume":"4","author":"Sardanelli","year":"2020","journal-title":"Eur. Radiol. Exp."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13300-019-00720-0","article-title":"The impact of flash glucose monitoring on glycaemic control as measured by HbA1c: A meta-analysis of clinical trials and real-world observational studies","volume":"11","author":"Evans","year":"2020","journal-title":"Diabetes Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2337\/dc19-1459","article-title":"Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: A systematic review with meta-analysis of randomized controlled trials","volume":"43","author":"Maiorino","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4093\/dmj.2022.0273","article-title":"Clinical and lifestyle determinants of continuous glucose monitoring metrics in insulin-treated patients with type 2 diabetes mellitus","volume":"47","author":"Kim","year":"2023","journal-title":"Diabetes Metab. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10730-020-09413-9","article-title":"Continuous glucose monitoring as a matter of justice","volume":"Volume 33","author":"Kraaijeveld","year":"2021","journal-title":"Hec Forum"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s13300-023-01431-3","article-title":"Expanding the role of continuous glucose monitoring in modern diabetes care beyond type 1 disease","volume":"14","author":"Klupa","year":"2023","journal-title":"Diabetes Ther."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2025). 7. Diabetes Technology: Standards of Care in Diabetes\u20142025. Diabetes Care, 48, S146\u2013S166.","DOI":"10.2337\/dc25-S007"},{"key":"ref_38","first-page":"429","article-title":"Using continuous glucose monitoring in clinical practice","volume":"38","author":"Miller","year":"2020","journal-title":"Clin. Diabetes A Publ. Am. Diabetes Assoc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1111\/dom.15608","article-title":"Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial","volume":"26","author":"Reed","year":"2024","journal-title":"Diabetes. Obes. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"991633","DOI":"10.3389\/fped.2022.991633","article-title":"Effect of nationwide reimbursement of real-time continuous glucose monitoring on HbA1c, hypoglycemia and quality of life in a pediatric type 1 diabetes population: The RESCUE-pediatrics study","volume":"10","author":"Charleer","year":"2022","journal-title":"Front. Pediatr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100324","DOI":"10.1016\/j.pecinn.2024.100324","article-title":"A combined diabetes and continuous glucose monitoring education program for adults with type 2 diabetes","volume":"5","author":"Lind","year":"2024","journal-title":"PEC Innov."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"112111","DOI":"10.1016\/j.diabres.2025.112111","article-title":"The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetes","volume":"223","author":"Battelino","year":"2025","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/13696998.2024.2405293","article-title":"Real-time continuous glucose monitoring vs. self-monitoring of blood glucose: Cost-utility in South Korean type 2 diabetes patients on intensive insulin","volume":"27","author":"Kim","year":"2024","journal-title":"J. Med. Econ."},{"key":"ref_44","unstructured":"American Diabetes Association Professional Practice Committee (2025). Introduction and Methodology: Standards of Care in Diabetes\u20142025. Diabetes Care, 48, S1\u2013S5."},{"key":"ref_45","first-page":"202","article-title":"Influence of obesity on blood glucose control using continuous glucose monitoring data among patients with type 1 diabetes","volume":"71","author":"Nicolau","year":"2024","journal-title":"Endocrinol. Diabetes Y Nutr. (Engl. Ed.)"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/pedi.13274","article-title":"Association of the use of diabetes technology with HbA1c and BMI-SDS in an international cohort of children and adolescents with type 1 diabetes: The SWEET project experience","volume":"22","author":"Marigliano","year":"2021","journal-title":"Pediatr. Diabetes"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12933-022-01598-2","article-title":"Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: An expert-based multidisciplinary Delphi consensus","volume":"21","author":"Genovese","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1089\/dia.2021.0263","article-title":"Budget impact of the flash continuous glucose monitoring system in Medicaid diabetes beneficiaries treated with intensive insulin therapy","volume":"23","author":"Frank","year":"2021","journal-title":"Diabetes Technol. Ther."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/10\/1543\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:20:18Z","timestamp":1759317618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/10\/1543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["life15101543"],"URL":"https:\/\/doi.org\/10.3390\/life15101543","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}